Pfizer Abandons AstraZeneca Bid But Its Tax Issues Live On – Forbes
The Guardian |
Pfizer Abandons AstraZeneca Bid But Its Tax Issues Live On
Forbes So another multi-billion dollar proposed merger between corporate giants is kaput. Pfizer Pfizer announced on Monday it is abandoning its unsolicited bid to acquire British pharmaceutical company AstraZeneca AstraZeneca after the company rejected its … Pfizer Walks Away From AstraZeneca Deal Pfizer withdraws £69 billion bid for AstraZeneca Pfizer walks away from 8 bln AstraZeneca takeover fight |
